Antimicrobial nonsusceptibility of gram-negative bloodstream isolates, veterans health administration system, United States, 2003-2013

Emerging Infectious Diseases

Volumn 23, Issue 11, 2017, Pages 1815-1825

  Goto, Michihiko ^a,b   McDanel, Jennifer S ^a,b   Jones, Makoto M ^c,d   Livorsi, Daniel J ^a,b   Ohl, Michael E ^a,b   Beck, Brice F ^a   Richardson, Kelly K ^a   Alexander, Bruce ^a   Perencevich, Eli N ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; CARBAPENEM; CEPHALOSPORIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT;

ACINETOBACTER; AGED; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL STEWARDSHIP; ARTICLE; BACTEREMIA; COHORT ANALYSIS; COMMUNITY ACQUIRED INFECTION; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; KLEBSIELLA; MALE; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; DRUG EFFECTS; GOVERNMENT; GRAM NEGATIVE INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; UNITED STATES; VETERAN;

ACINETOBACTER; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; COHORT STUDIES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; KLEBSIELLA; MALE; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDIES; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS;

EID: 85032014976     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.32301/eid2311.161216     Document Type: Article

References (48)

1. Moreno R, Afonso S, Fevereiro T. Incidence of sepsis in hospitalized patients. Curr Infect Dis Rep. 2006;8:346-50. http://dx.doi.org/10.1007/s11908-006-0044-2
2. Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013;19:501-9. http://dx.doi.org/10.1111/1469-0691.12195
3. Søgaard M, Nørgaard M, Dethlefsen C, Schønheyder HC. Temporal changes in the incidence and 30-day mortality associated with bacteremia in hospitalized patients from 1992 through 2006: a population-based cohort study. Clin Infect Dis. 2011;52:61-9. http://dx.doi.org/10.1093/cid/ciq069
4. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother. 2005;49:760-6. http://dx.doi.org/10.1128/AAC.49.2.760-766.2005
5. Gikas A, Samonis G, Christidou A, Papadakis J, Kofteridis D, Tselentis Y, et al. Gram-negative bacteremia in non-neutropenic patients: a 3-year review. Infection. 1998;26:155-9. http://dx.doi.org/10.1007/BF02771841
6. Albrecht SJ, Fishman NO, Kitchen J, Nachamkin I, Bilker WB, Hoegg C, et al. Reemergence of gram-negative health care-associated bloodstream infections. Arch Intern Med. 2006;166:1289-94. http://dx.doi.org/10.1001/archinte.166.12.1289
7. Luzzaro F, Ortisi G, Larosa M, Drago M, Brigante G, Gesu G. Prevalence and epidemiology of microbial pathogens causing bloodstream infections: results of the OASIS multicenter study. Diagn Microbiol Infect Dis. 2011;69:363-9. http://dx.doi.org/ 10.1016/j.diagmicrobio.2010.10.016
8. Prowle JR, Echeverri JE, Ligabo EV, Sherry N, Taori GC, Crozier TM, et al. Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality. Crit Care. 2011;15:R100. http://dx.doi.org/10.1186/cc10114
9. Biedenbach DJ, Moet GJ, Jones RN. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). Diagn Microbiol Infect Dis. 2004;50:59-69. http://dx.doi.org/10.1016/j.diagmicrobio.2004.05.003
10. Cordero L, Rau R, Taylor D, Ayers LW. Enteric gram-negative bacilli bloodstream infections: 17 years’ experience in a neonatal intensive care unit. Am J Infect Control. 2004;32:189-95. http://dx.doi.org/10.1016/j.ajic.2003.07.004
11. Laupland KB. Defining the epidemiology of bloodstream infections: the ‘gold standard’ of population-based assessment. Epidemiol Infect. 2013;141:2149-57. http://dx.doi.org/10.1017/S0950268812002725
12. Søgaard M, Lyytikäinen O, Laupland KB, Schønheyder HC. Monitoring the epidemiology of bloodstream infections: aims, methods and importance. Expert Rev Anti Infect Ther. 2013;11:1281-90. http://dx.doi.org/10.1586/14787210.2013.856262
13. Laupland KB. Incidence of bloodstream infection: a review of population-based studies. Clin Microbiol Infect. 2013;19:492-500. http://dx.doi.org/10.1111/1469-0691.12144
14. Veterans Health Administration. About VHA, July 5, 2016 [cited 2017 Aug 29]. http://www.va.gov/health/aboutVHA.asp
15. Goto M, O’Shea AM, Livorsi DJ, McDanel JS, Jones MM, Richardson KK, et al. The effect of a nationwide infection control program expansion on hospital-onset gram-negative rod bacteremia in 130 Veterans Health Administration Medical Centers: an interrupted time-series analysis. Clin Infect Dis. 2016;63:642-50. http://dx.doi.org/10.1093/cid/ciw423
16. Shorr AF, Tabak YP, Killian AD, Gupta V, Liu LZ, Kollef MH. Healthcare-associated bloodstream infection: a distinct entity? Insights from a large U.S. database. Crit Care Med. 2006;34:2588-95. http://dx.doi.org/10.1097/01.CCM.0000239121.09533.09
17. Sligl W, Taylor G, Brindley PG. Five years of nosocomial gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes. Int J Infect Dis. 2006;10:320-5. http://dx.doi.org/10.1016/j.ijid.2005.07.003
18. Luzzaro F, Viganò EF, Fossati D, Grossi A, Sala A, Sturla C, et al.; AMCLI Lombardia Hospital Infectious Study Group. Prevalence and drug susceptibility of pathogens causing bloodstream infections in northern Italy: a two-year study in 16 hospitals. Eur J Clin Microbiol Infect Dis. 2002;21:849-55.
19. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137:791-7. http://dx.doi.org/10.7326/0003-4819-137-10-200211190-00007
20. Al-Hasan MN, Eckel-Passow JE, Baddour LM. Impact of healthcare-associated acquisition on community-onset gram-negative blood-stream infection: a population-based study: healthcare-associated gram-negative BSI. Eur J Clin Microbiol Infect Dis. 2012;31:1163-71. http://dx.doi.org/10.1007/s10096-011-1424-6
21. Uslan DZ, Crane SJ, Steckelberg JM, Cockerill FR III, St Sauver JL, Wilson WR, et al. Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Arch Intern Med. 2007;167:834-9. http://dx.doi.org/10.1001/archinte.167.8.834
22. Rodríguez-Créixems M, Alcalá L, Muñoz P, Cercenado E, Vicente T, Bouza E. Bloodstream infections: evolution and trends in the microbiology workload, incidence, and etiology, 1985-2006. Medicine (Baltimore). 2008;87:234-49. http://dx.doi.org/10.1097/MD.0b013e318182119b
23. US Census Bureau. Our nation’s veterans. Distribution of civilian veterans, 18 years and over in the United States and Puerto Rico, July 29, 2017 [cited 2017 Aug 29]. https://www.census.gov/library/visualizations/2015/comm/our-nation-s-veterans.html
24. VHA. VHA Office of Rural Health, July 5, 2016 [cited 2017 Aug 29]. http://www.ruralhealth.va.gov/about/rural-veterans.asp
25. VHA. Facts about VA health care capabilities, July 5, 2016 [cited 2017 Aug 29]. http://www.publichealth.va.gov/docs/flu/pandemic/AppxA3_HealthCare.pdf
26. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309-32. http://dx.doi.org/10.1016/j.ajic.2008.03.002
27. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268-81. http://dx.doi.org/10.1111/j.1469-0691.2011.03570.x
28. Centers for Disease Control and Prevention. Age standardiza-tion and population estimates, July 27, 2017 [cited 2017 Aug 29]. https://www.cdc.gov/nchs/tutorials/NHANES/NHANESAnalyses/agestandardization/age_standardization_intro.htm
29. Clopper CJ, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika. 1934;26:404-13. http://dx.doi.org/10.1093/biomet/26.4.404
30. Skogberg K, Lyytikäinen O, Ollgren J, Nuorti JP, Ruutu P. Population-based burden of bloodstream infections in Finland. Clin Microbiol Infect. 2012;18:E170-6. http://dx.doi.org/10.1111/j.1469-0691.2012.03845.x
31. Bonten MJ, Slaughter S, Ambergen AW, Hayden MK, van Voorhis J, Nathan C, et al. The role of “colonization pressure” in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med. 1998;158:1127-32. http://dx.doi.org/10.1001/archinte.158.10.1127
32. Bonten MJ, Gaillard CA, Johanson WG Jr, van Tiel FH, Smeets HG, van der Geest S, et al. Colonization in patients receiving and not receiving topical antimicrobial prophylaxis. Am J Respir Crit Care Med. 1994;150:1332-40. http://dx.doi.org/ 10.1164/ajrccm.150.5.7952561
33. Jain R, Kralovic SM, Evans ME, Ambrose M, Simbartl LA, Obrosky DS, et al. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med. 2011;364:1419-30. http://dx.doi.org/10.1056/NEJMoa1007474
34. VHA. VHA directive 2011-007. Required hand hygiene practices, July 5, 2016 [cited 2017 Aug 29]. http://www1.va.gov/vhapublications/ViewPublication.asp?pub_ID=2367
35. Chou AF, Graber CJ, Jones M, Zhang Y, Goetz MB, Madaras-Kelly K, et al. Characteristics of antimicrobial stewardship programs at Veterans Affairs hospitals: results of a nationwide survey. Infect Control Hosp Epidemiol. 2016;37:647-54. http://dx.doi.org/10.1017/ice.2016.26
36. Overdevest I, Willemsen I, Rijnsburger M, Eustace A, Xu L, Hawkey P, et al. Extended-spectrum β-lactamase genes of Escherichia coli in chicken meat and humans, the Netherlands. Emerg Infect Dis. 2011;17:1216-22. http://dx.doi.org/10.3201/eid1707.110209
37. Pogorzelska-Maziarz M, Herzig CT, Larson EL, Furuya EY, Perencevich EN, Stone PW. Implementation of antimicrobial stewardship policies in U.S. hospitals: findings from a national survey. Infect Control Hosp Epidemiol. 2015;36:261-4. http://dx.doi.org/10.1017/ice.2014.50
38. Centers for Disease Control and Prevention. Percent of hospitals with antibiotic stewardship programs by state, 2014. July 5, 2016 [cited 2017 Aug 29]. http://www.cdc.gov/getsmart/community/pdfs/stewardship_11_13.pdf
39. Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, et al.; National Healthcare Safety Network (NHSN) Team and participating NHSN facilities. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol. 2013;34:1-14. http://dx.doi.org/10.1086/668770
40. Centers for Disease Control and Prevention. Tracking CRE, July 5, 2016 [cited 2017 Aug 29]. http://www.cdc.gov/hai/organisms/cre/TrackingCRE.html
41. Thaden JT, Lewis SS, Hazen KC, Huslage K, Fowler VG Jr, Moehring RW, et al. Rising rates of carbapenem-resistant enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States. Infect Control Hosp Epidemiol. 2014;35:978-83. http://dx.doi.org/10.1086/677157
42. Veterans Health Administration. VHA guideline for control of carbapenemase-producing carbapenem-resistant Enterobacteriaceae (CP-CRE). Washington (DC): MDRO Prevention Office, National Infectious Diseases Service, The Administration; 2015.
43. Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 21st informational supplement. Document M100-S21. Wayne (PA). The Institute; 2010.
44. Food and Drug Administration. Antibacterial and antifungal product labeling: microbiology susceptibility interpretive criteria (breakpoints) and quality control parameter updates, July 5, 2016 [cited 2017 Aug 29]. http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm275763.htm
45. Fisman D, Patrozou E, Carmeli Y, Perencevich E, Tuite AR, Mermel LA; Geographical Variability of Bacteremia Study Group. Geographical variability in the likelihood of bloodstream infections due to gram-negative bacteria: correlation with proximity to the equator and health care expenditure. PLoS One. 2014;9:e114548. http://dx.doi.org/10.1371/journal.pone.0114548
46. Hawkey PM, Jones AM. The changing epidemiology of resistance. J Antimicrob Chemother. 2009;64(Suppl 1):i3-10. http://dx.doi.org/10.1093/jac/dkp256
47. Wilson BM, El Chakhtoura NG, Patel S, Saade E, Donskey CJ, Bonomo RA, et al. Carbapenem-resistant Enterobacter cloacae in patients from the US Veterans Health Administration, 2006-2015. Emerg Infect Dis. 2017;23:878-80. http://dx.doi.org/10.3201/eid2305.162034
48. Livorsi DJ, Goto M, Carrel M, Jones MM, McDanel J, Nair R, et al. Regional variations in fluoroquinolone non-susceptibility among Escherichia coli bloodstream infections within the Veterans Healthcare Administration. Antimicrob Resist Infect Control. 2016;5:38. http://dx.doi.org/10.1186/s13756-016-0135-2